BENLYSTA
NDC 49401-088, belimumab, solution, from GlaxoSmithKline LLC.
- Product NDC
- 49401-088
- Status
- Listed
- Labeler
- GlaxoSmithKline LLC
- Dosage form
- SOLUTION
- Route
- SUBCUTANEOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- BLA
- Application
- BLA761043
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/49401-088 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- BELIMUMAB200 mg/mL
Pharmacologic classes
B Lymphocyte Stimulator-directed Antibody Interactions [MoA]; B Lymphocyte Stimulator-specific Inhibitor [EPC]; Decreased B Lymphocyte Activation [PE]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 49401-088-02 | 49401008802 | 1 SYRINGE in 1 CARTON (49401-088-02) / 1 mL in 1 SYRINGE (49401-088-01) |
| 49401-088-35 | 49401008835 | 4 SYRINGE in 1 CARTON (49401-088-35) / 1 mL in 1 SYRINGE (49401-088-01) |
| 49401-088-47 | 49401008847 | 4 SYRINGE in 1 CARTON (49401-088-47) / 1 mL in 1 SYRINGE (49401-088-42) |
| 49401-088-50 | 49401008850 | 1 SYRINGE in 1 CARTON (49401-088-50) / 1 mL in 1 SYRINGE (49401-088-42) |
| 49401-088-61 | 49401008861 | 1 SYRINGE in 1 CARTON (49401-088-61) / 1 mL in 1 SYRINGE |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/2fa3c528-1777-4628-8a55-a69dae2381a3
Use it
Look up 49401-088 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/49401-088 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 49401-088. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.